Profile data is unavailable for this security.
About the company
Shanghai Shen Lian Biomedical Corp is a China-based company principally engaged in the research, development, production and sale of veterinary biological products. The Company’s core business includes the research, development, production and sale of animal vaccines, pharmaceuticals and veterinary diagnostic products. The Company’s main products include genetically engineered subunit vaccine for classical swine fever and live pseudorabies vaccine for porcine pseudorabies, which can be used to prevent classical swine fever and pseudorabies. The Company distributes its products within the domestic market.
- Revenue in CNY (TTM)292.81m
- Net income in CNY-30.34m
- Incorporated2001
- Employees391.00
- LocationShanghai Shen Lian Biomedical CorpNo. 48Jiangchuan East Road, Minhang DistrictSHANGHAI 200241ChinaCHN
- Phone+86 2 161255101
- Fax+86 2 161267296
- Websitehttp://www.slbio.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhejiang Cheng Yi Pharmaceutical Co Ltd | 790.86m | 226.35m | 3.79bn | 738.00 | 16.55 | 2.87 | -- | 4.79 | 0.6997 | 0.6997 | 2.46 | 4.04 | 0.4508 | 1.95 | 20.88 | -- | 13.02 | 11.48 | 15.87 | 14.03 | 68.99 | 69.02 | 28.88 | 24.63 | 0.985 | -- | 0.0808 | 37.22 | 6.36 | 0.9546 | 23.21 | 8.84 | -20.09 | 11.39 |
| Henan Taloph Pharmaceutical Stock Co Ltd | 1.79bn | 46.95m | 3.83bn | 2.21k | 75.58 | 2.41 | -- | 2.14 | 0.0884 | 0.0884 | 3.31 | 2.78 | 0.4791 | 2.74 | 1.60 | 807,429.60 | 1.45 | 0.3241 | 3.13 | 0.6105 | 23.45 | 26.22 | 3.02 | 0.6331 | 0.9038 | 1.86 | 0.3592 | 52.82 | -6.21 | 8.16 | 16.00 | 2.61 | -19.14 | -- |
| Shanghai Shen Lian Biomedical Corp | 292.81m | -30.34m | 3.97bn | 391.00 | -- | 2.81 | -- | 13.55 | -0.0739 | -0.0739 | 0.713 | 3.43 | 0.1864 | 1.42 | 0.9144 | 748,865.90 | -2.21 | 3.53 | -2.40 | 3.80 | 57.36 | 73.49 | -11.87 | 16.93 | 3.64 | -- | 0.0106 | 43.52 | 0.6394 | 3.63 | -241.95 | -- | -3.99 | -- |
| Zhejiang Shouxiangu Pharmaceuticl Co Ltd | 649.78m | 132.39m | 4.10bn | 1.12k | 30.96 | 1.77 | -- | 6.31 | 0.668 | 0.668 | 3.30 | 11.66 | 0.2093 | 0.6222 | 8.34 | 581,201.90 | 4.26 | 8.88 | 4.86 | 10.35 | 78.29 | 83.01 | 20.37 | 28.55 | 3.19 | -- | 0.1984 | 45.94 | -11.81 | 4.81 | -31.34 | 7.12 | 40.84 | 0.3458 |
| Shanghai MicuRx Pharmaceutical Co Ltd | 136.70m | -342.96m | 4.12bn | 188.00 | -- | 15.99 | -- | 30.15 | -0.5197 | -0.5197 | 0.2077 | 0.3929 | 0.161 | 0.4661 | 3.95 | 727,105.00 | -40.40 | -31.40 | -53.04 | -35.41 | 84.26 | 82.42 | -250.89 | -503.67 | 2.15 | -406.30 | 0.5862 | -- | 43.51 | -- | -4.65 | -- | 51.72 | -- |
Data as of Feb 13 2026. Currency figures normalised to Shanghai Shen Lian Biomedical Corp's reporting currency: Chinese Yuan Renminbi CNY
1.94%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 1.88m | 0.74% |
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2025 | 1.34m | 0.53% |
| Gfund Management Co., Ltd.as of 30 Jun 2025 | 662.81k | 0.26% |
| Hongde Fund Management Co., Ltd.as of 30 Jun 2025 | 290.60k | 0.12% |
| Morgan Stanley Huaxin Fund Management Co., Ltd.as of 30 Jun 2025 | 151.60k | 0.06% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 142.80k | 0.06% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 126.25k | 0.05% |
| Huashang Fund Management Co., Ltd.as of 30 Jun 2025 | 117.60k | 0.05% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 93.78k | 0.04% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 93.37k | 0.04% |
More ▼
Data from 30 Jun 2025 - 30 Nov 2025Source: FactSet Research Systems Inc.
